Tag Archives: biotech

FDA delays PharmAthene anthrax study

PharmAthene Inc., of Annapolis, a biodefense company developing medical countermeasures against biological and chemical threats, announced that it has been notified by the Food and Drug Administration that its SparVax next-generation anthrax vaccine program has been placed on clinical hold.

Read More »

Fuel cell technology pioneered in Md.

A collaborative effort between a private Maryland-based company and a University of Maryland researcher is working to develop fuel cells to provide electricity to businesses, homes and eventually automobiles at about one-tenth the cost and one-tenth the size of current commercial fuel cell systems.

Read More »

Greenleaf named CEO of Mass. biotech

Peter Greenleaf, a respected figure in biotechnology circles with over 20 years of experience in the industry, has been named CEO of Waltham, Mass.-based Histogenics Corp.

Read More »